Can a new treatment combination stop breast cancer growth?


Associate Professor Elgene Lim

Associate Professor Elgene Lim

Garvan Institute of Medical ResearchCancer Council NSW Funding: $450,000Funding duration: 2017-2019

Background

Estrogen is a female hormone that promotes breast cancer growth, and drugs that counteract this effect (known as antiestrogenic drugs) are used to treat the disease. One such drug is tamoxifen, and the research team has discovered that another hormone, progesterone, enhances the antiestrogenic effect of Tamoxifen.

The research

This project will provide the critical clinical evidence on the effectiveness of adding progesterone to antiestrogenic therapies in patients with early stage breast cancer.

The impact

The researchers predict that this combination treatment will be more effective than the current standard of care in stopping tumour growth and improving patient outcomes. The results of this study will allow the researchers to move closer to initiating a clinical trial on a larger group of patients.

Cancer information

Find information by cancer type.
Learn about symptoms, diagnosis and treatment for specific cancer types.

Want to know more about research at Cancer Council?
How we conduct research and how the community can get involved.

Cancer glossary.
Common cancer terms explained.

Support Services

Coping with cancer?
Speak to a qualified health professional or someone who has experienced cancer, access support groups & forums.

Need legal and financial assistance?
Find out how to access our Pro Bono Program for legal and financial advice.

Looking for transport, accommodation or home help?
Practical advice and support during and after treatment.

TOP BACK TO TOP